Haoxi Health Technology Ltd
2 hedge funds and large institutions have $17.4K invested in Haoxi Health Technology Ltd in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
30% less capital invested
Capital invested by funds: $24.7K → $17.4K (-$7.34K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$1.62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$5.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.79K |
HAO Hedge Fund Activity: Q3 2025 in Review
2 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Haoxi Health Technology Ltd (HAO) for Q3 2025, worth a combined $17.4K — down 30% from $24.7K a quarter earlier.
Fund positioning in HAO was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $1.62K. The largest seller was UBS Group, exiting entirely with an estimated $5.9K sold.
- 2 institutional investors held Haoxi Health Technology Ltd (HAO) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $17.4K of Haoxi Health Technology Ltd stock for Q3 2025, down 30% quarter-over-quarter.
- 1 fund opened new Haoxi Health Technology Ltd positions in Q3 2025 and 1 closed out, a net change of 0 holders.
- The largest Haoxi Health Technology Ltd buyer in Q3 2025 was Toronto Dominion Bank, an estimated $1.62K added.
- The largest Haoxi Health Technology Ltd seller in Q3 2025 was UBS Group, an estimated $5.9K sold.
Based on aggregated 13F filings for Q3 2025.